- Fluorescence In Situ Hybridization
(FISH) (Technique) Market Share (in %) by Company in Europe: 2019 & 2025
erb-b2 amplification by fluorescence in situ hybridization
in breast cancer specimens read as 2+ in immunohistochemical analysis.
Defining the efficiency of fluorescence in situ hybridization
on uncultured amniocytes on a retrospective cohort of 27407 diagnosis.
Determination of HER2 gene amplification by fluorescence in situ hybridization
and concordance with the clinical trials immunohistochemicalassay in women with metastatic breast cancer evaluated for treatment with trastuzumab.
Metaphase and interphase fluorescence in situ hybridization
mapping of rice genome with bacterial artificial chromosomes.
HER-2/neu gene amplification characterized by fluorescence in situ hybridization
: poor prognosis in node-negative breast carcinomas.
Forty-seven chapters are divided into 11 sections: general histologic and cytologic features; immunophenotyping; introduction to cytogenetics; FISH (Fluorescence in situ Hybridization
), and molecular testing; mature B-cell neoplasms; mature T-cell neoplasm; Hodgkins lymphoma; myeloproliferative neoplasms; myelodysplastic syndromes and mixed myelodysplastic/myeloproliferative neoplasms; acute myeloid leukemia: an introduction; acute lymphoblastic leukemia and other hematopoietic tumors; extranodal lymphomas and their differential diagnosis.
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization
Like IHC, fluorescence in situ hybridization
(FISH)-based detection of the ERBB2 [v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian); also known as HER2] gene copy number is a morphologydriven slide-based assay that features DNA hybridization with fluorescently labeled probes (9).
In this study we investigated the diploid chromosome number and performed karyotype and fluorescence in situ hybridization
(FISH) analyses of the telomere sequence on chromosomes of T.
Although fluorescence in situ hybridization
(FISH) is only now becoming the standard technique for in-situ chromosomal investigation, already primed in situ (PRINS) labeling and peptide nucleic acid (PNA) probes are providing alternatives for detecting chromosomes and quantifying chromosomal abnormalities.
The Columbia researchers used a technique known as fluorescence in situ hybridization
to identify and count the number and types of chromosomal changes that occurred in a subset of 60 African-American and Dominican newborns from the Columbia Center for Children's Environmental Health Prospective Cohort Study in New York City.